Bharatbook added a new report on "Probiotic microorganisms the new drugs? The surge in the number of scientific articles and patents in recent times, on microbes that confer health benefits when consumed."
Bharatbook added a new report on "Biopolymer-Polyhydroxybutyrate - Patent and Technology Report this report highlights year-wise patent activity (trend line) along with the key industrial players in the field."
Bharatbook added a new report on " With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate.
Bharatbook added a new report on "International Directory of Biotechnology Companies 2011" which gives this report is one of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published.
Bharatbook.com has this special report, which sources information India is one of Malaysia has effectively witnessed an upsurge in the profitability and development of the domestic biotechnology industry.
Bharatbook.com has this special report, which sources information of The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector.
Nowadays, fatty acid esters are irreplaceable components in modern cosmetics and skin care products. The biocatalytic production of these esters gives broad advantages compared to the convenient chemically catalyzed processes in view of decreasing waste production and levels of undesired by products.
This new report added by BharatBook describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production.
BharatBook adds new report on "Biotechnology in the United States" which provides textual analysis of Biotechnology in the United States’s recent performance and future prospects.
BharatBook adds report on “Emerging Biotech Sector in Malaysia”, the biotech market in Malaysia is expected to grow at a CAGR of around 21% during 2010-2012.
Bharatbook added a new report on "International Directory of Biotechnology Companies 2010" which gives detailed information on the Biotechnology companies globally.
Bharatbook added a new report on "International Directory of Biotechnology Companies 2010" which gives detailed information on the Biotechnology companies globally.
The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
Although the history of the biotechnology industry dates back to the
late 19th century, It was only much later that biological organisms
began to be modified for applications in agriculture, industrial
production and medicine. The medical application of biotechnology began
in earnest in the 1970s, growth has been strong as novel new medicines
have been approved for conditions not previously treatable with
conventional pharmaceuticals. Because they are biologically-derived but
used for similar purposes as pharmaceutical products, these medications
are also referred to as “biopharmaceuticals”. ( http://www.bharatbook.com/detail.asp?id=154523&rt=The-Top-10-Biotechnology-Companies-Positioning-performance-and-SWOT-analyses.html )
Biopharmaceuticals can be defined as therapeutics manufactured by
biotechnology methods from biological sources, usually involving live
organisms or their active components (bioprocessing, or directly
involving surrogates, e.g., protein/gene sequences).
For the purpose of this report, biopharmaceuticals include the
following broad therapeutic classes which can be further divided into
other sub-classes:
Monoclonal antibodies;
Therapeutic proteins (inclusive of Insulin and analogs, erythropoietins,
interferon alpha, interferon beta, blood coagulation factors, human
growth hormone, enzymes, follicle stimulating hormone)
Vaccines (inclusive of vaccines manufactured only by recombinant technology)
Monoclonal antibodies were the largest sub-category, accounting for
approximately half of the global biotechnology market in 2009. Hormones
such as insulin & analogs, human growth hormone, and follicle
stimulating hormone were the second largest sub-category. Growth
factors, including erythropoietin and granulocyte colony stimulating
factors were the third largest sub-category. Interferons, comprising of
interferons alpha and beta were the fourth largest sub-category. The
fifth in order were coagulation factors such as blood factors and
coagulants. The last two sub-categories were of therapeutic enzymes and
recombinant vaccines.
Key Features
• Overview of the global biotech industry
• Impact of the US healthcare reform on the biotech industry
• Market dynamics and performance of key sub-categories in 2009
• Detailed profiles of the top 10 global biotech players
• Strategic growth analyses and SWOT analyses of the top 10 global biotechnology players
• Short profiles of other leading players
RSS